학술논문 – 법학도서관

학술논문

replay검색결과 돌아가기

search검색화면

1811P Patient-reported outcomes (PROs) in men with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) mutations receiving talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA: Results from a phase III (TALAPRO-2) study

Document Type

Abstract

Author

Fay, A.P.; Fizazi, K.; Matsubara, N.; Azad, A.A.; Saad, F.; De Giorgi, U.F.F.; Joung, J.Y.; Fong, P.C.; Jones, R.J.; Zschäbitz, S.; Oldenburg, J.; Shore, N.D.; Dunshee, C.; Carles Galceran, J.; Cislo, P.; Chang, J.; Healy, C.G.; Niyazov, A.; Agarwal, N.

Source

In Annals of Oncology October 2023 34 Supplement 2:S980-S981

Subject

Language

ISSN

0923-7534

Online Access

Full Text (ScienceDirect 종량제) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일